These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11052245

  • 21. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M, Agarwal K, Arshad Q, Hariri M, Rea P, Seemungal BM, Golding JF, Harcourt JP, Bronstein AM.
    Lancet; 2016 Dec 03; 388(10061):2753-2762. PubMed ID: 27865535
    [Abstract] [Full Text] [Related]

  • 22. Intratympanic gentamicin treatment for Meniere's disease.
    McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ.
    Otolaryngol Head Neck Surg; 1998 May 03; 118(5):589-96. PubMed ID: 9591855
    [Abstract] [Full Text] [Related]

  • 23. Low-dose intratympanic gentamicin treatment of Menière's disease.
    Inoue H, Uchi Y, Nogami K, Uemura T.
    Eur Arch Otorhinolaryngol; 1994 May 03; 251 Suppl 1():S12-4. PubMed ID: 11894767
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome.
    Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ.
    Otol Neurotol; 2001 Mar 03; 22(2):210-4. PubMed ID: 11300271
    [Abstract] [Full Text] [Related]

  • 25. Use of the round window microcatheter in the treatment of Meniere's disease.
    Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, Balaban C.
    Laryngoscope; 2001 Nov 03; 111(11 Pt 1):2046-9. PubMed ID: 11801994
    [Abstract] [Full Text] [Related]

  • 26. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan 03; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 27. Chemical perfusion of the inner ear.
    Jackson LE, Silverstein H.
    Otolaryngol Clin North Am; 2002 Jun 03; 35(3):639-53. PubMed ID: 12486845
    [Abstract] [Full Text] [Related]

  • 28. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun 20; 30(12):942-944. PubMed ID: 29771059
    [Abstract] [Full Text] [Related]

  • 29. Chemical and physical labyrinthectomy for Meniere's disease.
    Berryhill WE, Graham MD.
    Otolaryngol Clin North Am; 2002 Jun 20; 35(3):675-82. PubMed ID: 12486847
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF, Renk E, Rauch SD, Xu HX.
    Otol Neurotol; 2017 Aug 20; 38(7):1005-1009. PubMed ID: 28538472
    [Abstract] [Full Text] [Related]

  • 31. Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease. Rationale for extremely low dose therapy.
    Magnusson M, Padoan S.
    Acta Otolaryngol; 1991 Aug 20; 111(4):671-6. PubMed ID: 1950529
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Menière's disease and gentamicin: preliminary results using the minimum effective dose and integrated therapy.
    Sala T.
    Acta Otorhinolaryngol Ital; 2003 Apr 20; 23(2):78-87. PubMed ID: 14526554
    [Abstract] [Full Text] [Related]

  • 34. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G, Chung DW, van der Hoeven R, Verweij S, Becker M.
    Int J Clin Pharm; 2016 Aug 20; 38(4):780-3. PubMed ID: 27073077
    [Abstract] [Full Text] [Related]

  • 35. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul 20; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 36. Intratympanic gentamicin in bilateral Menière's disease.
    Pyykkö I, Ishizaki H, Kaasinen S, Aalto H.
    Otolaryngol Head Neck Surg; 1994 Feb 20; 110(2):162-7. PubMed ID: 8108151
    [Abstract] [Full Text] [Related]

  • 37. Preclinical and clinical studies of unrelieved aural fullness following intratympanic gentamicin injection in patients with intractable Ménière's disease.
    Zhai F, Zhang R, Zhang T, Steyger PS, Dai CF.
    Audiol Neurootol; 2013 Feb 20; 18(5):297-306. PubMed ID: 24008307
    [Abstract] [Full Text] [Related]

  • 38. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT, Parnes LS.
    Am J Otol; 1999 May 20; 20(3):357-63. PubMed ID: 10337978
    [Abstract] [Full Text] [Related]

  • 39. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep 20; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.